CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$0.62
-0.01 (-2.07%)
Open$0.63
Previous Close$0.63
Day High$0.64
Day Low$0.61
52W High$4.72
52W Low$0.59
Volume—
Avg Volume97.7K
Market Cap4.10M
P/E Ratio—
EPS$-1.97
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+5,315.2% upside
Current
$0.62
$0.62
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 16.5K | 40.6K | 749.0K |
| Net Income | -16,586,871 | -36,814,263 | -154,552 |
| Profit Margin | -99,916.8% | -94,921.0% | -20.6% |
| EBITDA | -16,654,115 | -39,017,038 | -155,667 |
| Free Cash Flow | — | — | -141,548 |
| Rev Growth | -59.5% | -59.5% | +1.8% |
| Debt/Equity | — | — | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |